Central nervous system infections in immunocompromised patients - Update on diagnostics and therapy

Leukemia and Lymphoma

Volumn 50, Issue 1, 2009, Pages 24-36

  Schmidt Hieber, Martin ^a   Zweigner, Janine ^a   Uharek, Lutz ^a   Blau, Igor W ^a   Thiel, Eckhard ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Central nervous system infections; Diagnosis; Fungi; Immunocompromised patients; Neoplasms; Therapy; Viruses

Indexed keywords

ACICLOVIR; ALEMTUZUMAB; AMPHOTERICIN B DEOXYCHOLATE; AMPHOTERICIN B LIPID COMPLEX; AMPICILLIN; CASPOFUNGIN; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CIDOFOVIR; CLINDAMYCIN; COTRIMOXAZOLE; CYTARABINE; FLUCONAZOLE; FLUCYTOSINE; FLUDARABINE; FOLINIC ACID; FOSCARNET; GANCICLOVIR; INTERLEUKIN 2; ITRACONAZOLE; METHOTREXATE; POSACONAZOLE; PYRIMETHAMINE; RITUXIMAB; SULFADIAZINE; TOBRAMYCIN; UNINDEXED DRUG; VIDARABINE; VORICONAZOLE;

ABSCESS DRAINAGE; ALLOGENEIC STEM CELL TRANSPLANTATION; ANAMNESIS; ASPERGILLUS; BACTEROIDES; BRAIN BIOPSY; CANDIDA; CENTRAL NERVOUS SYSTEM INFECTION; CEREBROSPINAL FLUID ANALYSIS; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; CRANIOTOMY; CRYPTOCOCCUS NEOFORMANS; CYTOMEGALOVIRUS; DRUG BRAIN LEVEL; DRUG CEREBROSPINAL FLUID LEVEL; DRUG MEGADOSE; DRUG PENETRATION; ENTEROBACTERIACEAE; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIOLOGICAL DATA; EPSTEIN BARR VIRUS; EVIDENCE BASED MEDICINE; HERPES SIMPLEX VIRUS; HUMAN; HUMAN HERPESVIRUS 6; IMMUNOCOMPROMISED PATIENT; INFECTION RISK; JC VIRUS; LISTERIA; MALIGNANT NEOPLASTIC DISEASE; MEDICAL DECISION MAKING; MONOTHERAPY; MYCOBACTERIUM TUBERCULOSIS; NEISSERIA MENINGITIDIS; NEUROIMAGING; NOCARDIA; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOGENESIS; PHYSICAL EXAMINATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; PSEUDOMONAS; REVIEW; STAPHYLOCOCCUS; STREPTOCOCCUS PNEUMONIAE; SYMPTOM; T CELL DEPLETION; TOXOPLASMA; TOXOPLASMA GONDII; TREATMENT OUTCOME; VARICELLA ZOSTER VIRUS; ZYGOMYCETES;

ANIMALS; BIOPSY; CENTRAL NERVOUS SYSTEM INFECTIONS; HUMANS; IMMUNOCOMPROMISED HOST; RISK FACTORS;

EID: 59349112390     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190802517740     Document Type: Review

References (119)

1. Kish, M. A. (2001) Guide to development of practice guidelines. Clin Infect Dis, 32, pp. 851-854.
2. Maschke, M., Dietrich, U., Prumbaum, M., Kastrup, O., Turowski, B. Schaefer, U. W. et al. (1999) Opportunistic CNS infection after bone marrow transplantation. Bone Marrow Transplant, 23, pp. 1167-1176.
3. Denier, C., Bourhis, J. H., Lacroix, C., Koscielny, S., Bosq, J. Sigal, R. et al. (2006) Spectrum and prognosis of neurologic complications after hematopoietic transplantation. Neurology, 67, pp. 1990-1997.
4. Hagensee, M. E., Bauwens, J. E., Kjos, B. and Bowden, R. A. (1994) Brain abscess following marrow transplantation: Experience at the Fred Hutchinson Cancer Research Center 1984-1992. Clin Infect Dis, 19, pp. 402-408.
5. Zuber, P. and Jacquier, P. (1995) Epidemiology of toxoplasmosis: worldwide status. Schweiz Med Wochenschr Suppl, 65, pp. 19S-22S.
6. Tseng, J. H. and Tseng, M. Y. (2006) Brain abscess in 142 patients: factors influencing outcome and mortality. Surg Neurol, 65, pp. 557-562.
7. Sommers, L. M. and Hawkins, D. S. (1999) Meningitis in pediatric cancer patients: A review of forty cases from a single institution. Pediatr Infect Dis J, 18, pp. 902-907.
8. Cabellos, C., Viladrich, P. F., Corredoira, J., Verdaguer, R., Ariza, J. and Gudiol, F. (1999) Streptococcal meningitis in adult patients: current epidemiology and clinical spectrum. Clin Infect Dis, 28, pp. 1104-1108.
9. Safdar, A., Papadopoulous, E. B. and Armstrong, D. (2002) Listeriosis in recipients of allogeneic blood and marrow transplantation: Thirteen year review of disease characteristics, treatment outcomes and a new association with human cytomegalovirus infection. Bone Marrow Transplant, 29, pp. 913-916.
10. Gerner-Smidt, P., Ethelberg, S., Schiellerup, P., Christensen, J. J., Engberg, J. Fussing, V. et al. (2005) Invasive listeriosis in Denmark 1994-2003: A review of 299 cases with special emphasis on risk factors for mortality. Clin Microbiol Infect, 11, pp. 618-624.
11. Anaissie, E. J., Kontoyiannis, D. P., O'Brien, S., Kantarjian, H., Robertson, L. Lerner, S. et al. (1998) Infections in patients with chronic lymphocytic leukemia treated with fludarabine. Ann Intern Med, 129, pp. 559-566.
12. Mattiuzzi, G. and Giles, F. J. (2005) Management of intracranial fungal infections in patients with haematological malignancies. Br J Haematol, 131, pp. 287-300.
13. Safdieh, J. E., Mead, P. A., Sepkowitz, A., Kiehn, T. E. and Abrey, L. E. (2008) Bacterial and fungal meningitis in patients with cancer. Neurology, 70, pp. 943-947.
14. Schroeder, P. C., Post, M. J., Oschatz, E., Stadler, A., Bruce-Gregorios, J. and Thurnher, M. M. (2006) Analysis of the utility of diffusion-weighted MRI and ADC values in distinguishing central nervous system toxoplasmosis from lymphoma. Neuroradiology, 48, pp. 715-720.
15. Charlot, M., Pialat, J. B., Obadia, N., Boibieux, A., Streichenberger, N. Meyronnet, D. et al. (2007) Diffusion-weighted imaging in brain aspergillosis. Eur J Neurol, 14, pp. 912-916.
16. Deisenhammer, F., Bartos, A., Egg, R., Gilhus, N. E., Giovannoni, G. Rauer, S. et al. (2006) EFNS task force. Guidelines on routine cerebrospinal fluid analysis. Report from an EFNS task force. Eur J Neurol, 13, pp. 913-922.
17. Hall, W. A., Martinez, A. J., Dummer, J. S. and Lunsford, L. D. (1987) Nocardial brain abscess: Diagnostic and therapeutic use of stereotactic aspiration. Surg Neurol, 28, pp. 114-118.
18. Xiao, F., Tseng, M. Y., Teng, L. J., Tseng, H. M. and Tsai, J. C. (2005) Brain abscess: Clinical experience and analysis of prognostic factors. Surg Neurol, 63, pp. 442-449.
19. Salonen, J. H. (2006) Successful management of cerebral and pulmonary mucormycosis with liposomal amphotericin B in a 28-year-old woman with acute lymphoblastic leukemia. Acta Biomed, 77, pp. 28-31.
20. Chimelli, L. and Mahler-Araujo, M. B. (1997) Fungal infections. Brain Pathol, 7, pp. 613-627.
21. Parker, J CJ, McCloskey, J. J. and Lee, R. S. (1978) The emergence of candidosis. The dominant postmortem cerebral mycosis. Am J Clin Pathol, 70, pp. 31-36.
22. Schwartz, S., Ruhnke, M., Ribaud, P., Reed, E., Troke, P. and Thiel, E. (2007) Poor efficacy of amphotericin B-based therapy in CNS aspergillosis. Mycoses, 50, pp. 196-200.
23. Ascioglu, S., Rex, J. H., de Pauw, B., Bennett, J. E., Bille, J. Crokaert, F. et al. (2002) Invasive fungal infections cooperative group of the European organization for research and treatment of cancer; Mycoses study group of the national institute of allergy and infectious diseases. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: An international consensus. Clin Infect Dis, 34, pp. 7-14.
24. Hamer, E. C., Moore, C. B. and Denning, D. W. (2006) Comparison of two fluorescent whiteners, Calcofluor and Blankophor, for the detection of fungal elements in clinical specimens in the diagnostic laboratory. Clin Microbiol Infect, 12, pp. 181-184.
25. Verweij, P. E., Brinkman, K., Kremer, H. P., Kullberg, B-J and Meis, J. F. (1999) Aspergillus meningitis: Diagnosis by non-culture-based microbiological methods and management. J Clin Microbiol, 37, pp. 1186-1189.
26. Yeo, S. F. and Wong, B. (2002) Current status of nonculture methods for diagnosis of invasive fungal infections. Clin Microbiol Rev, 3, pp. 465-484.
27. Florent, M., Katsahian, S., Vekhoff, A., Levy, V., Rio, B. Marie, J. P. et al. (2006) Prospective evaluation of a PCR-ELISA targeted to A. fumigatus and A. flavus for the early diagnosis of invasive aspergillosis in patients with hematological malignancies. J Infect Dis, 193, pp. 741-747.
28. Schwartz, S., Ruhnke, M., Ribaud, P., Corey, L., Driscoll, T. Cornely, O. A. et al. (2005) Improved outcome in central nervous system aspergillosis, using voriconazole treatment. Blood, 106, pp. 2641-2645.
29. Schwartz, S., Milatovic, D. and Thiel, E. (1997) Successful treatment of cerebral aspergillosis with a novel triazole (voriconazole) in a patient with acute leukaemia. Br J Haematol, 97, pp. 663-665.
30. Lutsar, I., Roffey, S. and Troke, P. (2003) Voriconazole concentrations in the cerebrospinal fluid and brain tissue of guinea pigs and immunocompromised patients. Clin Infect Dis, 37, pp. 728-732.
31. Black, K. E. and Baden, L. R. (2007) Fungal infections of the CNS: treatment strategies for the immunocompromised patient. CNS Drugs, 21, pp. 293-318.
32. Kume, H., Yamazaki, T., Abe, M., Tanuma, H., Okudaira, M. and Okayasu, I. (2003) Increase in Aspergillosis and severe mycotic infection in patients with leukemia and MDS: Comparison of the data from the Annual of the pathological autopsy cases in Japan in 1989, 1993 and 1997. Pathol Int, 53, pp. 744-750.
33. McCullers, J. A., Vargas, S. L., Flynn, P. M., Razzouk, B. I. and Shenep, J. L. (2000) Candidal meningitis in children with cancer. Clin Infect Dis, 31, pp. 451-457.
34. Dorko, E., Pilipcinec, E. and Tkacikova, L. (2002) Candida species isolated from cerebrospinal fluid. Folia Microbiol (Praha), 47, pp. 179-181.
35. Sanchez-Portocarrero, J., Perez-Cecilia, E., Corral, O., Romero-Vivas, J. and Picazo, J. J. (2000) The central nervous system and infection by Candida species. Diagn Microbiol Infect Dis, 37, pp. 169-179.
36. Chen, T. L., Tsai, C. A., Fung, C. P., Lin, M. Y., Yu, K. W. and Liu, C. Y. (2002) Clinical significance of Candida species isolated from cerebrospinal fluid. J Microbiol Immunol Infect, 35, pp. 249-254.
37. Liu, K. H., Wu, C. J., Chou, C. H., Lee, H. C., Lee, N. Y. Hung, S. T. et al. (2004) Refractory candidal meningitis in an immunocompromised patient cured by caspofungin. J Clin Microbiol, 42, pp. 5950-5953.
38. Shea, Y. R. (2007) Algorithms for detection and identification of fungi. Manual of Clinical Microbiology, pp. 1745-1761. ASM, Washington, DC
39. Verduyn Lunel, F M, Voss, A., Kuijper, E. J., Gelinck, L. B., Hoogerbrugge, P. M. Liem, K. L. et al. (2004) Detection of the Candida antigen mannan in cerebrospinal fluid specimens from patients suspected of having Candida meningitis. J Clin Microbiol, 42, pp. 867-870.
40. Pappas, P. G., Rex, J. H., Sobel, J. D., Filler, S. G., Dismukes, W. E. Walsh, T. J. et al. (2004) Infectious diseases society of America. Guidelines for treatment of candidiasis. Clin Infect Dis, 38, pp. 161-189.
41. Pruitt, A. A. (2004) Central nervous system infections in cancer patients. Semin Neurol, 24, pp. 435-452.
42. Scarcella, A., Pasquariello, M. B., Giugliano, B., Vendemmia, M. and de Lucia, A. (1998) Liposomal amphotericin B treatment for neonatal fungal infections. Pediatr Infect Dis J, 17, pp. 146-148.
43. Ghannoum, M. A., Okogbule-Wonodi, I., Bhat, N. and Sanati, H. (1999) Antifungal activity of voriconazole (UK-109,496), fluconazole and amphotericin B against hematogenous Candida krusei infection in neutropenic guinea pig model. J Chemother, 11, pp. 34-39.
44. Nissapatorn, V., Lee, C., Fatt, Q. K. and Abdullah, K. A. (2003) AIDS-related opportunistic infections in Hospital Kuala Lumpur. Jpn J Infect Dis, 56, pp. 187-192.
45. Patterson, T. F. and Andriole, V. T. (1989) Current concepts in cryptococcosis. Eur J Clin Microbiol Infect Dis, 8, pp. 457-465.
46. Cunha, B. A. (2001) Central nervous system infections in the compromised host: A diagnostic approach. Infect Dis Clin North Am, 15, pp. 567-590.
47. Rappelli, P., Are, R., Casu, G., Fiori, P. L., Cappuccinelli, P. and Aceti, A. (1998) Development of a nested PCR for detection of Cryptococcus neoformans in cerebrospinal fluid. J Clin Microbiol, 36, pp. 3438-3440.
48. Paschoal, R. C., Hirata, M. H., Hirata, R. C., Melhem Mde, S, Dias, A. L. and Paula, C. R. (2004) Neurocryptococcosis: Diagnosis by PCR method. Rev Inst Med Trop Sao Paulo, 46, pp. 203-207.
49. Bovers, M., Diaz, M. R., Hagen, F., Spanjaard, L., Duim, B. Visser, C. E. et al. (2007) Identification of genotypically diverse Cryptococcus neoformans and Cryptococcus gattii isolates by Luminex xMAP technology. J Clin Microbiol, 45, pp. 1874-1883.
50. Gottfredsson, M. and Perfect, J. R. (2000) Fungal meningitis. Semin Neurol, 20, pp. 307-322.
51. Brouwer, A. E., Rajanuwong, A., Chierakul, W., Griffin, G. E., Larsen, R. A. White, N. J. et al. (2004) Combination antifungal therapies for HIV-associated cryptococcal meningitis: A randomised trial. Lancet, 363, pp. 1764-1767.
52. Kirkpatrick, W. R., Najvar, L. K., Bocanegra, R., Patterson, T. F. and Graybill, J. R. (2007) New guinea pig model of Cryptococcal meningitis. Antimicrob Agents Chemother, 51, pp. 3011-3033.
53. Gleissner, B., Schilling, A., Anagnostopolous, I., Siehl, J. and Thiel, E. (2004) Improved outcome of zygomycosis in patients with hematological diseases?. Leuk Lymphoma, 45, pp. 1351-1360.
54. Zaoutis, T. E., Roilides, E., Chiou, C. C., Buchanan, W. L., Knudsen, T. A. Sarkisova, T. A. et al. (2007) Zygomycosis in children: A systematic review and analysis of reported cases. Pediatr Infect Dis J, 26, pp. 723-727.
55. Howells, R. C. and Ramadan, H. H. (2001) Usefulness of computed tomography and magnetic resonance in fulminant invasive fungal rhinosinusitis. Am J Rhinol, 15, pp. 255-261.
56. Sundaram, C., Mahadevan, A., Laxmi, V., Yasha, T. C., Santosh, V. Murthy, J. M. et al. (2005) Cerebral zygomycosis. Mycoses, 48, pp. 396-407.
57. Chamilos, G., Lewis, R. E. and Kontoyiannis, D. P. (2008) Delaying amphotericin B-based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis. Clin Infect Dis, 47, pp. 503-509.
58. Gil-Lamaignere, C., Hess, R., Salvenmoser, S., Heyn, K., Kappe, R. and Muller, F. M. (2005) Effect of media composition and in vitro activity of posaconazole, caspofungin and voriconazole against zygomycetes. J Antimicrob Chemother, 55, pp. 1016-1019.
59. Greenberg, R. N., Mullane, K., van Burik, J. A., Raad, I., Abzug, M. J. Anstead, G. et al. (2006) Posaconazole as salvage therapy for zygomycosis. Antimicrob Agents Chemother, 50, pp. 126-133.
60. Kauffman, C. A. and Malani, A. N. (2007) Zygomycosis: An emerging fungal infection with new options for management. Curr Infect Dis Rep, 9, pp. 435-440.
61. Torres-Narbona, M., Guinea, J., Martinez-Alarcon, J., Pelaez, T. and Bouza, E. (2007) In vitro activities of amphotericin B, caspofungin, itraconazole, posaconazole, and voriconazole against 45 clinical isolates of zygomycetes: Comparison of CLSI M38-A, Sensititre YeastOne, and the Etest. Antimicrob Agents Chemother, 51, pp. 1126-1129.
62. Sun, Q. N., Fothergill, A. W., McCarthy, D. I., Rinaldi, M. G. and Graybill, J. R. (2002) In vitro activities of posaconazole, itraconazole, voriconazole, amphotericin B, and fluconazole against 37 clinical isolates of zygomycetes. Antimicrob Agents Chemother, 46, pp. 1581-1582.
63. Gea-Banacloche, J., Johnson, R. T., Bagic, A., Butman, J. A., Murray, P. R. and Agrawal, A. G. (2004) West Nile virus: Pathogenesis and therapeutic options. Ann Intern Med, 140, pp. 545-553.
64. Whitley, R. J. (2006) Herpes simplex encephalitis: Adolescents and adults. Antiviral Res, 71, pp. 141-148.
65. Raschilas, F., Wolff, M., Delatour, F., Chaffaut, C., De Broucker, T. Chevret, S. et al. (2002) Outcome of and prognostic factors for herpes simplex encephalitis in adult patients: Results of a multicenter study. Clin Infect Dis, 35, pp. 254-260.
66. Suzuki, H. I., Hangaishi, A., Hosoya, N., Watanabe, T., Kanda, Y. Motokura, T. et al. (2008) Herpes simplex encephalitis and subsequent cytomegalovirus encephalitis after chemoradiotherapy for central nervous system lymphoma: A case report and literature review. Int J Hematol, 87, pp. 538-541.
67. Al-Shekhlee, A., Kocharian, N. and Suarez, J. J. (2006) Re-evaluating the diagnostic methods in herpes simplex encephalitis. Herpes, 13, pp. 17-19.
68. Skoldenberg, B., Forsgren, M., Alestig, K., Bergstrom, T., Burman, L. Dahlqvist, E. et al. (1984) Acyclovir versus vidarabine in Herpes simplex encephalitis. Randomised multicentre study in consecutive Swedish patients. Lancet, 2, pp. 707-711.
69. Whitley, R. J., Alford, C. A., Hirsch, M. S., Schooley, R. T., Luby, J. P. Aoki, F. Y. et al. (1986) Vidarabine versus acyclovir therapy in herpes simplex encephalitis. N Engl J Med, 314, pp. 144-149.
70. Kamei, S., Sekizawa, T., Shiota, H., Mizutani, T., Itoyama, Y. Takasu, T. et al. (2005) Evaluation of combination therapy using aciclovir and corticosteroid in adult patients with herpes simplex virus encephalitis. J Neurol Neurosurg Psychiatry, 76, pp. 1544-1549.
71. Musallam, B., Matoth, I., Wolf, D. G., Engelhard, D. and Averbuch, D. (2007) Steroids for deteriorating herpes simplex virus encephalitis. Pediatr Neurol, 37, pp. 229-232.
72. Koskiniemi, M., Piiparinen, H., Rantalaiho, T., Eranko, P., Farkkila, M. Raiha, K. et al. (2002) Acute central nervous system complications in varicella zoster virus infections. J Clin Virol, 25, pp. 293-301.
73. Hackanson, B., Zeiser, R., Bley, T. A., Pantazis, G., Huzly, D. Bertz, H. et al. (2005) Fatal varicella zoster virus encephalitis in two patients following allogeneic hematopoietic stem cell transplantation. Clin Transplant, 19, pp. 566-570.
74. Aberle, S. W., Aberle, J. H., Steininger, C. and Puchhammer-Stockl, E. (2005) Quantitative real time PCR detection of Varicella-zoster virus DNA in cerebrospinal fluid in patients with neurological disease. Med Microbiol Immunol, 194, pp. 7-12.
75. Snoeck, R., Andrei, G. and De Clercq, E. (2000) Novel agents for the therapy of varicella-zoster virus infections. Expert Opin Investig Drugs, 9, pp. 1743-1751.
76. Julin, J. E., van Burik, J. H., Krivit, W., Webb, C., Holman, C. J. Clark, H. B. et al. (2002) Ganciclovir-resistant cytomegalovirus encephalitis in a bone marrow transplant recipient. Transpl Infect Dis, 4, pp. 201-206.
77. Zeiser, R., Grullich, C., Bertz, H., Pantazis, G., Hufert, F. T. Bley, T. A. et al. (2004) Late cytomegalovirus polyradiculopathy following haploidentical CD34 + -selected hematopoietic stem cell transplantation. Bone Marrow Transplant, 33, pp. 243-245.
78. Chaudhuri, A. and Kennedy, P. G. (2002) Diagnosis and treatment of viral encephalitis. Postgrad Med J, 78, pp. 575-583.
79. Maschke, M., Kastrup, O. and Diener, H. C. (2002) CNS manifestations of cytomegalovirus infections: Diagnosis and treatment. CNS Drugs, 16, pp. 303-315.
80. Anduze-Faris, B. M., Fillet, A. M., Gozlan, J., Lancar, R., Boukli, N. Gasnault, J. et al. (2000) Induction and maintenance therapy of cytomegalovirus central nervous system infection in HIV-infected patients. AIDS, 14, pp. 517-524.
81. Weinberg, A., Li, S., Palmer, M. and Tyler, K. L. (2002) Quantitative CSF PCR in Epstein-Barr virus infections of the central nervous system. Ann Neurol, 52, pp. 543-548.
82. Kinch, A., Oberg, G., Arvidson, J., Falk, K. I., Linde, A. and Pauksens, K. (2007) Post-transplant lymphoproliferative disease and other Epstein-Barr virus diseases in allogeneic haematopoietic stem cell transplantation after introduction of monitoring of viral load by polymerase chain reaction. Scand J Infect Dis, 39, pp. 235-244.
83. Dellemijn, P. L., Brandenburg, A., Niesters, H. G., van den Bent, M J, Rothbarth, P. H. and Vlasveld, L. T. (1995) Successful treatment with ganciclovir of presumed Epstein-Barr meningo-encephalitis following bone marrow transplant. Bone Marrow Transplant, 16, pp. 311-312.
84. Bossolasco, S., Falk, K. I., Ponzoni, M., Ceserani, N., Crippa, F. Lazzarin, A. et al. (2006) Ganciclovir is associated with low or undetectable Epstein-Barr virus DNA load in cerebrospinal fluid of patients with HIV-related primary central nervous system lymphoma. Clin Infect Dis, 42, pp. e21-e25.
85. Nozzoli, C., Bartolozzi, B., Guidi, S., Orsi, A., Vannucchi, A. M. Leoni, F. et al. (2006) Epstein-Barr virus-associated post-transplant lymphoproliferative disease with central nervous system involvement after unrelated allogeneic hematopoietic stem cell transplantation. Leuk Lymphoma, 47, pp. 167-169.
86. Van de Glind, G., de Graaf, S., Klein, C., Cornelissen, M., Maecker, B. and Loeffen, J. (2008) Intrathecal rituximab treatment for pediatric post-transplant lymphoproliferative disorder of the central nervous system. Pediatr Blood Cancer, 50, pp. 886-888.
87. Zerr, D. M., Corey, L., Kim, H. W., Huang, M. L., Nguy, L. and Boeckh, M. (2005) Clinical outcomes of human Herpesvirus 6 reactivation after hematopoietic stem cell transplantation. Clin Infect Dis, 40, pp. 932-940.
88. Zerr, D. M. (2006) Human Herpesvirus 6 and central nervous system disease in hematopoietic cell transplantation. J Clin Virol, 37, pp. S52-S56.
89. Seeley, W. W., Marty, F. M., Holmes, T. M., Upchurch, K., Soiffer, R. J. Antin, J. H. et al. (2007) Post-transplant acute limbic encephalitis: clinical features and relationship to HHV6. Neurology, 69, pp. 156-165.
90. Pohlmann, C., Schetelig, J., Reuner, U., Bornhauser, M., Illmer, T. Kiani, A. et al. (2007) Cidofovir and foscarnet for treatment of human Herpesvirus 6 encephalitis in a neutropenic stem cell transplant recipient. Clin Infect Dis, 44, pp. e118-e120.
91. Kiewe, P., Seyfert, S., Korper, S., Rieger, K., Thiel, E. and Knauf, W. (2003) Progressive multifocal leukoencephalopathy with detection of JC virus in a patient with chronic lymphocytic leukemia parallel to onset of fludarabine therapy. Leuk Lymphoma, 44, pp. 1815-1818.
92. Delbue, S., Marchioni, E., Sotgiu, G., Saresella, M., Tavazzi, E. Colombo, E. et al. (2007) Longitudinal study of two cases of progressive multifocal leukoencephalopathy with a clinical benign evolution. J Neurovirol, 13, pp. 268-273.
93. Diller, R. and Thompson, K. (2007) Visual loss secondary to acquired immunodeficiency virus-related progressive multifocal leukoencephalopathy demonstrating clinical improvement with highly active antiretroviral therapy. Optometry, 78, pp. 63-70.
94. Kharfan-Dabaja, M. A., Ayala, E., Greene, J., Rojiani, A., Murtagh, F. R. and Anasetti, C. (2007) Two cases of progressive multifocal leukoencephalopathy after allogeneic hematopoietic cell transplantation and a review of the literature. Bone Marrow Transplant, 39, pp. 101-107.
95. Viallard, J. F., Lazaro, E., Ellie, E., Eimer, S., Camou, F. Caubet, O. et al. (2007) Improvement of progressive multifocal leukoencephalopathy after cidofovir therapy in a patient with a destructive polyarthritis. Infection, 35, pp. 33-36.
96. Walker, M., Kublin, J. G. and Zunt, J. R. (2006) Parasitic central nervous system infections in immunocompromised hosts: Malaria, microsporidiosis, leishmaniasis, and African trypanosomiasis. Clin Infect Dis, 42, pp. 115-125.
97. Luft, B. J., Hafner, R., Korzun, A. H., Leport, C., Antoniskis, D. Bosler, E. M. et al. (1993) Toxoplasmic encephalitis in patients with the acquired immunodeficiency syndrome. Members of the ACTG 077p/ANRS 009 Study Team. N Engl J Med, 329, pp. 995-1000.
98. Roemer, E., Blau, I. W., Basara, N., Kiehl, M. G., Bischoff, M. Gunzelmann, S. et al. (2001) Toxoplasmosis, a severe complication in allogeneic hematopoietic stem cell transplantation: Successful treatment strategies during a 5-year single-center experience. Clin Infect Dis, 32, pp. E1-E8.
99. Bacchu, S., Fegan, C. and Neal, J. (2007) Cerebral toxoplasmosis in a patient with chronic lymphocytic leukaemia treated with fludarabine. Br J Haematol, 139, p. 349.
100. Lim, Z., Baker, B., Zuckerman, M., Wade, J. J., Ceesay, M. Ho, A. Y. et al. (2007) Toxoplasmosis following alemtuzumab based allogeneic haematopoietic stem cell transplantation. J Infect, 54, pp. e83-e86.
101. Slavin, M. A., Meyers, J. D., Remington, J. S. and Hackman, R. C. (1994) Toxoplasma gondii infection in marrow transplant recipients: A 20 year experience. Bone Marrow Transplant, 13, pp. 549-557.
102. Antinori, A., Ammassari, A., De Luca, A., Cingolani, A., Murri, R. Scoppettuolo, G. et al. (1997) Diagnosis of AIDS-related focal brain lesions: A decision-making analysis based on clinical and neuroradiologic characteristics combined with polymerase chain reaction assays in CSF. Neurology, 48, pp. 687-694.
103. Bretagne, S., Costa, J. M., Foulet, F., Jabot-Lestang, L., Baud-Camus, F. and Cordonnier, C. (2000) Prospective study of toxoplasma reactivation by polymerase chain reaction in allogeneic stem-cell transplant recipients. Transpl Infect Dis, 3, pp. 127-132.
104. Vidal, J. E., Colombo, F. A., de Oliveira, A. C., Focaccia, R. and Pereira-Chioccola, V. L. (2004) PCR assay using cerebrospinal fluid for diagnosis of cerebral toxoplasmosis in Brazilian AIDS patients. J Clin Microbiol, 42, pp. 4765-4768.
105. Chandramukhi, A. (2004) Diagnosis of neurotoxoplasmosis by antibody detection in cerebrospinal (CSF) fluid using Latex Agglutination Test and ELISA. J Commun Dis, 36, pp. 153-158.
106. Katlama, C., De Wit, S., O'Doherty, E., Van Glabeke, M. and Clumeck, N. (1996) Pyrimethamine-clindamycin vs. pyrimethamine-sulfadiazine as acute and long-term therapy for toxoplasmic encephalitis in patients with AIDS. Clin Infect Dis, 22, pp. 268-275.
107. Dannemann, B., McCutchan, J. A., Israelski, D., Antoniskis, D., Leport, C. Luft, B. et al. (1992) Treatment of toxoplasmic encephalitis in patients with AIDS. A randomized trial comparing pyrimethamine plus clindamycin to pyrimethamine plus sulfadiazine. The California Collaborative Treatment Group. Ann Intern Med, 116, pp. 33-43.
108. Torre, D., Casari, S., Speranza, F., Donisi, A., Gregis, G. Poggio, A. et al. (1998) Randomized trial of trimethoprim-sulfamethoxazole versus pyrimethamine-sulfadiazine for therapy of toxoplasmic encephalitis in patients with AIDS. Italian Collaborative Study Group. Antimicrob Agents Chemother, 42, pp. 1346-1349.
109. Lukes, S. A., Posner, J. B., Nielsen, S. and Armstrong, D. (1984) Bacterial infections of the CNS in neutropenic patients. Neurology, 34, pp. 269-275.
110. Carpentier, A. F., Bernard, L., Poisson, M. and Delattre, J. Y. (1996) Central nervous system infections in patients with malignant diseases. Rev Neurol (Paris), 152, pp. 587-601.
111. Martino, R., Martinez, C., Brunet, S., Sureda, A., Lopez, R. and Domingo-Albos, A. (1996) Tuberculosis in bone marrow transplant recipients: Report of two cases and review of the literature. Bone Marrow Transplant, 18, pp. 809-812.
112. Weiser, M. A., O'Brien, S., Escalante, C. and Manzullo, E. (1999) Tuberculosis meningitis in a patient with acute myelogenous leukemia. Leuk Lymphoma, 33, pp. 187-192.
113. Tunkel, A. R. and Scheld, W. M. (1995) Acute bacterial meningitis. Lancet, 346, pp. 1675-1680.
114. Rivero, G. A., Torres, H. A., Rolston, K. V. and Kontoyiannis, D. P. (2003) Listeria monocytogenes infection in patients with cancer. Diagn Microbiol Infect Dis, 47, pp. 393-398.
115. Chang, W. N., Lu, C. H., Wu, J. J., Chang, H. W. Tsai, Y. C. et al. (2001) Staphylococcus aureus meningitis in adults: A clinical comparison of infections caused by methicillin-resistant and methicillin-sensitive strains. Infection, 29, pp. 245-250.
116. Viale, P., Pagani, L., Cristini, F., Stefini, R., Bergomi, R. Colombini, P. et al. (2002) Linezolid for the treatment of central nervous system infections in neurosurgical patients. Scand J Infect Dis, 34, pp. 456-459.
117. Brown-Elliott, B. A., Brown, J. M., Conville, P. S. and Wallace Jr, R. J. (2006) Clinical and laboratory features of the Nocardia spp. based on current molecular taxonomy. Clin Microbiol Rev, 19, pp. 259-282.
118. De Gans, J. and van de Beek, D. (2002) European dexamethasone in adulthood bacterial meningitis study investigators. dexamethasone in adults with bacterial meningitis. N Engl J Med, 347, pp. 1549-1556.
119. Van de Beek, D., de Gans, J., McIntyre, P. and Prasad, K. (2004) Steroids in adults with acute bacterial meningitis: A systematic review. Lancet Infect Dis, 4, pp. 139-143.